Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Mimedx (MDXG) over the last 16 years, with Q3 2025 value amounting to $64.9 million.

  • Mimedx's Non-Current Assets fell 955.93% to $64.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $277.5 million, marking a year-over-year decrease of 918.66%. This contributed to the annual value of $72.0 million for FY2024, which is 368.65% down from last year.
  • Per Mimedx's latest filing, its Non-Current Assets stood at $64.9 million for Q3 2025, which was down 955.93% from $70.2 million recorded in Q2 2025.
  • Mimedx's Non-Current Assets' 5-year high stood at $82.8 million during Q1 2024, with a 5-year trough of $34.5 million in Q3 2023.
  • Moreover, its 5-year median value for Non-Current Assets was $39.5 million (2021), whereas its average is $52.5 million.
  • As far as peak fluctuations go, Mimedx's Non-Current Assets soared by 12719.37% in 2024, and later crashed by 1511.57% in 2025.
  • Mimedx's Non-Current Assets (Quarter) stood at $39.4 million in 2021, then decreased by 5.52% to $37.2 million in 2022, then surged by 100.86% to $74.8 million in 2023, then decreased by 3.69% to $72.0 million in 2024, then fell by 9.91% to $64.9 million in 2025.
  • Its Non-Current Assets stands at $64.9 million for Q3 2025, versus $70.2 million for Q2 2025 and $70.3 million for Q1 2025.